There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In this process, once a clinician has determined a need for a tissue biopsy after detecting an abnormality, diagnostic accuracy and efficiency become crucial factors in the treatment journey.
We’ve seen great advancements when it comes to screening and targeted therapies. However, these treatments cannot occur without an accurate and timely diagnosis.
Read More
Digital Pathology
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology
The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-changer. This international standard, already widely used in radiology, is poised to transform how pathology images and data are stored, shared, and analyzed.
By promoting interoperability among various hardware and software solutions, DICOM empowers laboratories to build more efficient and scalable digital pathology
Read More
Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine
What You Should Know:
- Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with participation from Mayo Clinic and growth financing from HTGF, alongisde existing investors Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and VC Fonds Technologie managed by IBB Ventures.
- Aignostics combines proprietary access to multimodal clinical data with cutting-edge AI technology and rigorous
Read More
Bioptimus and Proscia Accelerate AI Development in Pathology with H-optimus-0 Integration
What You Should Know:
- Bioptimus, a French startup developing cutting-edge AI foundation models for biology, has announced a strategic partnership with Proscia, a provider of AI-enabled pathology solutions.
- The collaboration integrates Bioptimus' H-optimus-0 foundation model into Proscia's Concentriq® Embeddings, empowering researchers and data scientists to achieve breakthroughs in AI development at an unprecedented pace.
Unlocking the Power of Foundation
Read More
Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit
What You Should Know:
- Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.
- These powerful new tools empower life sciences organizations to leverage the full potential of artificial intelligence in pathology, leading to faster breakthroughs and improved patient outcomes.
Transforming AI Development in Pathology
Integrated into
Read More
PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows
What You Should Know:
- PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution.
- The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial
Read More
Fimlab to Deploy Proscia’s AI-Enabled Digital Pathology Platform
What You Should Know:
- Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.
- This collaboration will leverage Proscia's software platform to enhance Fimlab's digital pathology capabilities and drive more precise results.
The Benefits of Digital Pathology
Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to
Read More
Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba
What You Should Know:
- Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
- Leveraging the power of Paige's Foundation Models, Alba delivers real-time AI-driven patient insights, marking a significant step towards Artificial General Intelligence (AGI).
A Cohesive Solution for Personalized Medicine
Paige Alba
Read More
PathAI’s AISight Dx Receives CE Mark for Primary Diagnosis
What You Should Know:
- PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.
- The certification paves the way for PathAI's expansion into the European diagnostic pathology market, offering pathologists a powerful tool to enhance their interpretations and improve laboratory efficiency.
AISight Dx: A Comprehensive Digital Pathology
Read More
